Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

268.13 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,405
Open 268.13
Bid (Size) 271.70 (1)
Ask (Size) 272.65 (1)
Prev. Close 268.13
Today's Range 268.13 - 268.13
52wk Range 223.25 - 468.55
Shares Outstanding 149,033,443
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application (NDA) for Zuranolone to the U.S. Food & Drug Administration in the Second Half of 2022 with Rolling Submission Expected to
Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) today announced their plan to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for zuranolone, an... 
From Business Wire News Releases
Healthy Climate, Healthy Lives: Advancing Strategic Collaborations
Tags Biogen NASDAQ:BIIB Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News

Performance

YTD
+10.36%
+10.36%
1 Month
-10.17%
-10.17%
3 Month
-16.86%
-16.86%
6 Month
-1.86%
-1.86%
1 Year
-0.24%
-0.24%

More News

Read More
Expert Ratings For Biogen
Tags Market News BZI/AAR BIIB
From Benzinga
U.S. stock futures struggle ahead of more earnings, with Tesla due after the close
Tags COMP ABT ES00
From MarketWatch
Earnings Outlook For Biogen
Tags Earnings BZI/EP Market News
From Benzinga
2 Stocks That Could Grow Your Portfolio Over the Next Decade
Tags Market News NVO LLY
From Motley Fool
3 Biotech Stocks That Are Ridiculously Overpriced
Tags BIIB MRNA SAVA
From Motley Fool
Biogen's Antisense Candidate Flunks In Late-Stage Neurodegenerative Disorder Trial
Tags BIIB Benzinga Health Care
From Benzinga
Ionis Stock Collapses On Another 'Misstep' As Biogen-Partnered ALS Drug Flops
From Investor's Business Daily
Here’s ‘one of the most bullish signals’ ever for bitcoin that many investors may have missed
Tags BIIB Z FB
From MarketWatch
Analyst Ratings For Biogen
Tags BIIB Benzinga Analyst Ratings
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.